A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node—ablated, His bundle-paced dog

Introduction: Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic atrioventricular node—ablated, His bundle-paced Dog for defining drug induced cardiac repolarization prolongation. A novel predict...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacological and toxicological methods Vol. 53; no. 1; pp. 1 - 10
Main Authors Nolan, Emily R., Feng, Meihua Rose, Koup, Jeffrey R., Liu, Jing, Turluck, Daniel, Zhang, Yiqun, Paulissen, Jerome B., Olivier, N. Bari, Miller, Teresa, Bailie, Marc B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction: Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic atrioventricular node—ablated, His bundle-paced Dog for defining drug induced cardiac repolarization prolongation. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation was generated from these data. Methods: Three male beagle dogs underwent radiofrequency AV nodal ablation, and placement of a His bundle-pacing lead and programmable pacemaker under anesthesia. Each dog was restrained in a sling for a series of increasing dose infusions of each drug while maintained at a constant heart rate of 80 beats/min. RT interval, a surrogate for QT interval in His bundle-paced dogs, was recorded throughout the experiment. Results: E-4031 induced a statistically significant RT prolongation at the highest three doses. Cisapride resulted in a dose-dependent increase in RT interval, which was statistically significant at the two highest doses. Terfenadine induced a dose-dependent RT interval prolongation with a statistically significant change occurring only at the highest dose. The relationship between drug concentration and RT interval change was described by a sigmoid E max model with an effect site. Maximum RT change ( E max), free drug concentration at half of the maximum effect (EC 50), and free drug concentration associated with a 10 ms RT prolongation (EC 10 ms) were estimated. A linear correlation between EC 10 ms and HERG IC 50 values was identified. Discussion: The conscious dog with His bundle-pacing detects delayed cardiac repolarization related to I Kr inhibition, and detects repolarization change induced by drugs with activity at multiple ion channels. A clinically relevant sensitivity and a linear correlation with in vitro HERG data make the conscious His bundle-paced dog a valuable tool for detecting repolarization effect of new chemical entities.
AbstractList Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic atrioventricular node--ablated, His bundle-paced Dog for defining drug induced cardiac repolarization prolongation. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation was generated from these data. Three male beagle dogs underwent radiofrequency AV nodal ablation, and placement of a His bundle-pacing lead and programmable pacemaker under anesthesia. Each dog was restrained in a sling for a series of increasing dose infusions of each drug while maintained at a constant heart rate of 80 beats/min. RT interval, a surrogate for QT interval in His bundle-paced dogs, was recorded throughout the experiment. E-4031 induced a statistically significant RT prolongation at the highest three doses. Cisapride resulted in a dose-dependent increase in RT interval, which was statistically significant at the two highest doses. Terfenadine induced a dose-dependent RT interval prolongation with a statistically significant change occurring only at the highest dose. The relationship between drug concentration and RT interval change was described by a sigmoid E(max) model with an effect site. Maximum RT change (E(max)), free drug concentration at half of the maximum effect (EC(50)), and free drug concentration associated with a 10 ms RT prolongation (EC(10 ms)) were estimated. A linear correlation between EC(10 ms) and HERG IC(50) values was identified. The conscious dog with His bundle-pacing detects delayed cardiac repolarization related to I(Kr) inhibition, and detects repolarization change induced by drugs with activity at multiple ion channels. A clinically relevant sensitivity and a linear correlation with in vitro HERG data make the conscious His bundle-paced dog a valuable tool for detecting repolarization effect of new chemical entities.
Introduction: Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic atrioventricular node—ablated, His bundle-paced Dog for defining drug induced cardiac repolarization prolongation. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation was generated from these data. Methods: Three male beagle dogs underwent radiofrequency AV nodal ablation, and placement of a His bundle-pacing lead and programmable pacemaker under anesthesia. Each dog was restrained in a sling for a series of increasing dose infusions of each drug while maintained at a constant heart rate of 80 beats/min. RT interval, a surrogate for QT interval in His bundle-paced dogs, was recorded throughout the experiment. Results: E-4031 induced a statistically significant RT prolongation at the highest three doses. Cisapride resulted in a dose-dependent increase in RT interval, which was statistically significant at the two highest doses. Terfenadine induced a dose-dependent RT interval prolongation with a statistically significant change occurring only at the highest dose. The relationship between drug concentration and RT interval change was described by a sigmoid E max model with an effect site. Maximum RT change ( E max), free drug concentration at half of the maximum effect (EC 50), and free drug concentration associated with a 10 ms RT prolongation (EC 10 ms) were estimated. A linear correlation between EC 10 ms and HERG IC 50 values was identified. Discussion: The conscious dog with His bundle-pacing detects delayed cardiac repolarization related to I Kr inhibition, and detects repolarization change induced by drugs with activity at multiple ion channels. A clinically relevant sensitivity and a linear correlation with in vitro HERG data make the conscious His bundle-paced dog a valuable tool for detecting repolarization effect of new chemical entities.
Introduction: Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic atrioventricular node; ablated, His bundle-paced Dog for defining drug induced cardiac repolarization prolongation. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation was generated from these data. Methods: Three male beagle dogs underwent radiofrequency AV nodal ablation, and placement of a His bundle-pacing lead and programmable pacemaker under anesthesia. Each dog was restrained in a sling for a series of increasing dose infusions of each drug while maintained at a constant heart rate of 80 beats/min. RT interval, a surrogate for QT interval in His bundle-paced dogs, was recorded throughout the experiment. Results: E- 4031 induced a statistically significant RT prolongation at the highest three doses. Cisapride resulted in a dose-dependent increase in RT interval, which was statistically significant at the two highest doses. Terfenadine induced a dose- dependent RT interval prolongation with a statistically significant change occurring only at the highest dose. The relationship between drug concentration and RT interval change was described by a sigmoid E sub(max) model with an effect site. Maximum RT change (E sub(max)), free drug concentration at half of the maximum effect (EC sub(50)), and free drug concentration associated with a 10 ms RT prolongation (EC sub(10 ms)) were estimated. A linear correlation between EC sub(10 ms) and HERG IC sub(50) values was identified. Discussion: The conscious dog with His bundle-pacing detects delayed cardiac repolarization related to I sub(Kr) inhibition, and detects repolarization change induced by drugs with activity at multiple ion channels. A clinically relevant sensitivity and a linear correlation with in vitro HERG data make the conscious His bundle- paced dog a valuable tool for detecting repolarization effect of new chemical entities.
Author Nolan, Emily R.
Paulissen, Jerome B.
Liu, Jing
Feng, Meihua Rose
Miller, Teresa
Bailie, Marc B.
Turluck, Daniel
Olivier, N. Bari
Zhang, Yiqun
Koup, Jeffrey R.
Author_xml – sequence: 1
  givenname: Emily R.
  surname: Nolan
  fullname: Nolan, Emily R.
  email: emily.nolan@pfizer.com
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 2
  givenname: Meihua Rose
  surname: Feng
  fullname: Feng, Meihua Rose
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 3
  givenname: Jeffrey R.
  surname: Koup
  fullname: Koup, Jeffrey R.
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 4
  givenname: Jing
  surname: Liu
  fullname: Liu, Jing
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 5
  givenname: Daniel
  surname: Turluck
  fullname: Turluck, Daniel
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 6
  givenname: Yiqun
  surname: Zhang
  fullname: Zhang, Yiqun
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 7
  givenname: Jerome B.
  surname: Paulissen
  fullname: Paulissen, Jerome B.
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 8
  givenname: N. Bari
  surname: Olivier
  fullname: Olivier, N. Bari
  organization: Michigan State University College of Veterinary Medicine, East Lansing, MI, United States
– sequence: 9
  givenname: Teresa
  surname: Miller
  fullname: Miller, Teresa
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
– sequence: 10
  givenname: Marc B.
  surname: Bailie
  fullname: Bailie, Marc B.
  organization: Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16399550$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu1DAUtVARfcAXICGvWDWpncSJs2BRVYUiVWIDEjvrxr7ueEjswc5Eald8BN_GB_AleDpTdcfKvtI5595zzik58sEjIW85Kznj7cW6XCBpX1aMiZJVJWP1C3LCZVcXjZTfj_KfibaQHe-PyWlKa5YRPW9ekWPe1n0vBDshfy6pDwuOdBPROD27BelmBXECHX44j7PTF0-zufcwOU2nYDIhWBpxE0aI7gFmF3yWCGPwd_vBYMxahtoYJjqvkKK1qOe0480YLXowWf-capdgE51BCt7Q66JhNafOP3J08Em7sE1Ur2LweTcs-V6Df3_9hmGEGc05vXGJDltvRiw2oPNKE-5ek5cWxoRvDu8Z-fbx-uvVTXH75dPnq8vbQtdtPxeyaQaAuqsqy9qOdxxQcy6tkGBlx6DSDKtOto2ojGhQm1ow2Rs9dML0bGD1GXm_183ef24xzWpySeM4gsd8tuJdIyTnfQbWe6COIaWIVmXPE8R7xZna1anW6rFOtatTsUrlsjLr3UF-O0xonjmH_jLgwx6A2eTiMKqcF_qcgos5bWWC---Cf3ZnuYM
CitedBy_id crossref_primary_10_3109_00498254_2014_991366
crossref_primary_10_1016_j_vascn_2007_05_002
crossref_primary_10_1017_S146114570700805X
crossref_primary_10_1016_j_vascn_2022_107229
crossref_primary_10_2165_00126839_200708040_00002
crossref_primary_10_1016_j_vascn_2011_03_002
crossref_primary_10_1016_j_vascn_2014_05_004
crossref_primary_10_1016_j_autneu_2008_04_004
crossref_primary_10_7567_JJAP_55_06GN07
crossref_primary_10_1016_j_ejps_2017_05_024
crossref_primary_10_1016_j_toxlet_2012_10_018
crossref_primary_10_1016_j_vascn_2006_02_009
Cites_doi 10.1016/S0009-9236(98)90137-0
10.1016/S0167-5273(97)00331-8
10.1007/BF01744586
10.1016/j.ejphar.2003.12.028
10.1080/00498250110054632
10.1023/A:1014460404352
10.1056/NEJMra032426
10.1046/j.1540-8167.2001.00411.x
10.1046/j.1540-8167.2003.03215.x
10.1046/j.1460-9592.2002.00209.x
10.1016/S0008-6363(02)00846-5
10.2165/00003088-200039010-00004
10.2165/00003495-199039040-00006
10.1097/00005344-199423030-00003
10.1111/j.1540-8159.2004.00664.x
10.1007/BF02691087
10.1097/00045391-200103000-00006
10.1136/hrt.55.3.253
10.1038/clpt.1991.206
10.1111/j.1365-2125.1981.tb01123.x
10.1016/S0735-1097(02)01852-1
10.1111/j.1540-8159.1999.tb00635.x
10.1111/j.1542-474X.2004.93533.x
10.1097/00005344-199511000-00013
10.1161/01.CIR.103.15.2004
10.1016/j.jelectrocard.2004.08.004
10.1124/jpet.102.035220
10.2165/00002018-199921001-00006
10.1001/jama.1993.03500120051025
10.1046/j.1472-8206.2002.00098.x
ContentType Journal Article
Copyright 2005 Elsevier Inc.
Copyright_xml – notice: 2005 Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
C1K
DOI 10.1016/j.vascn.2005.02.003
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE

Toxicology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-488X
EndPage 10
ExternalDocumentID 10_1016_j_vascn_2005_02_003
16399550
S1056871905000225
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFRF
ABJNI
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
UHS
WUQ
ZGI
ZXP
~G-
AAHBH
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
C1K
ID FETCH-LOGICAL-c369t-844baa3722f067171aec118f58af870a2c0e2786452d54ecd35089dcb75d90b03
IEDL.DBID AIKHN
ISSN 1056-8719
IngestDate Fri Aug 16 07:42:43 EDT 2024
Thu Sep 26 18:32:31 EDT 2024
Sat Sep 28 07:52:57 EDT 2024
Fri Feb 23 02:30:05 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords QT interval
Repolarization
Cardiovascular
His bundle-pacing
Dog
Methods
Pharmacokinetic/pharmacodynamic modeling
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c369t-844baa3722f067171aec118f58af870a2c0e2786452d54ecd35089dcb75d90b03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16399550
PQID 17458119
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_17458119
crossref_primary_10_1016_j_vascn_2005_02_003
pubmed_primary_16399550
elsevier_sciencedirect_doi_10_1016_j_vascn_2005_02_003
PublicationCentury 2000
PublicationDate 2006-01-00
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – month: 01
  year: 2006
  text: 2006-01-00
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of pharmacological and toxicological methods
PublicationTitleAlternate J Pharmacol Toxicol Methods
PublicationYear 2006
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Fujiki, Tani, Mizumake, Shimono, Inhoue (bib7) 1994; 23
Redfern, Wakefield, Prior, Pollard, Hammond, Valentin (bib26) 2002; 16
Roden (bib27) 2004; 350
Olivier, Eyster, Sanders, Cheng, Bohart, Girand (bib23) 2003; 14
Gras, Llenas (bib9) 1999; 21
Gladziwa, Bares, Klotz, Dakshinamurty, Ittel, Seiler (bib8) 1991; 50
McTavish, Goa, Ferrill (bib19) 1990; 39
Yelamanchi, Molnar, Ranade, Somberg (bib32) 2001; 8
Ming, Nordin (bib22) 1995; 26
Minematsu, Ohtani, Yamada, Sawada, Sato, Iga (bib21) 2001; 6
Sanders, Bailie, Olivier (bib28) 2004; 27
Lainee, Perez, Dubreuil, Gillet (bib15) 1998; 26
Fossa, Depasquale, Raunig, Avery, Leishman (bib5) 2002; 202
Holford, Coates, Guentert, Riegelman, Sheiner (bib10) 1981; 11
Hondeghem, Carlsson, Duker (bib11) 2001; 103
Chiladakis, Karapanos, Manolis (bib4) 1998; 64
Redfern, Carlsson, Davis, Lynch, MacKenzie, Palethorpe (bib25) 2003; 58
Aytemir, Maarouf, Gallager, Yap, Waktare, Malik (bib2) 1999; 22
Huang, Hull, Foreman, Lazzara, Wolf (bib13) 1992; 27
Fossa, Wisialowski, Wolfgang, Wang, Avery, Raunig (bib6) 2004; 486
Antzelevitch (bib1) 2004; 37
Khan, Nair (bib14) 2004; 9
Malik (bib18) 2002; 25
Usui, Sugiyama, Ishida, Satoh, Sasaki, Hashimoto (bib29) 1998; 13
Van Haarst, Van't Klooster, Van Gerven, Schoemaker, Van Oene, Burggraaf (bib30) 1998; 64
Webster, Allan, Anto-Awuakye, Harrison, Kidd, Leishman (bib31) 2001; 31
Michalets, Williams (bib20) 2000; 39
Bexton, Vallin, Camm (bib3) 1986; 55
Oto, Breithardt (bib24) 2001
Honig, Wortham, Zamani, Conner, Mullin, Cantilena (bib12) 1993; 269
Magnano, Holleran, Ramakrishnan, Reiffel, Bloomfield (bib16) 2002; 39
Malik (bib17) 2001; 12
Olivier (10.1016/j.vascn.2005.02.003_bib23) 2003; 14
Sanders (10.1016/j.vascn.2005.02.003_bib28) 2004; 27
Bexton (10.1016/j.vascn.2005.02.003_bib3) 1986; 55
Chiladakis (10.1016/j.vascn.2005.02.003_bib4) 1998; 64
Redfern (10.1016/j.vascn.2005.02.003_bib25) 2003; 58
Oto (10.1016/j.vascn.2005.02.003_bib24) 2001
Roden (10.1016/j.vascn.2005.02.003_bib27) 2004; 350
Aytemir (10.1016/j.vascn.2005.02.003_bib2) 1999; 22
Hondeghem (10.1016/j.vascn.2005.02.003_bib11) 2001; 103
Malik (10.1016/j.vascn.2005.02.003_bib18) 2002; 25
Gras (10.1016/j.vascn.2005.02.003_bib9) 1999; 21
Usui (10.1016/j.vascn.2005.02.003_bib29) 1998; 13
Lainee (10.1016/j.vascn.2005.02.003_bib15) 1998; 26
Michalets (10.1016/j.vascn.2005.02.003_bib20) 2000; 39
Antzelevitch (10.1016/j.vascn.2005.02.003_bib1) 2004; 37
Gladziwa (10.1016/j.vascn.2005.02.003_bib8) 1991; 50
Khan (10.1016/j.vascn.2005.02.003_bib14) 2004; 9
Malik (10.1016/j.vascn.2005.02.003_bib17) 2001; 12
Redfern (10.1016/j.vascn.2005.02.003_bib26) 2002; 16
Yelamanchi (10.1016/j.vascn.2005.02.003_bib32) 2001; 8
Fossa (10.1016/j.vascn.2005.02.003_bib6) 2004; 486
Holford (10.1016/j.vascn.2005.02.003_bib10) 1981; 11
Van Haarst (10.1016/j.vascn.2005.02.003_bib30) 1998; 64
Fossa (10.1016/j.vascn.2005.02.003_bib5) 2002; 202
Minematsu (10.1016/j.vascn.2005.02.003_bib21) 2001; 6
Ming (10.1016/j.vascn.2005.02.003_bib22) 1995; 26
Huang (10.1016/j.vascn.2005.02.003_bib13) 1992; 27
Magnano (10.1016/j.vascn.2005.02.003_bib16) 2002; 39
McTavish (10.1016/j.vascn.2005.02.003_bib19) 1990; 39
Webster (10.1016/j.vascn.2005.02.003_bib31) 2001; 31
Honig (10.1016/j.vascn.2005.02.003_bib12) 1993; 269
Fujiki (10.1016/j.vascn.2005.02.003_bib7) 1994; 23
References_xml – volume: 55
  start-page: 253
  year: 1986
  end-page: 258
  ident: bib3
  article-title: Diurnal variation of the QT interval—influence of the autonomic nervous system
  publication-title: British Heart Journal
  contributor:
    fullname: Camm
– volume: 486
  start-page: 209
  year: 2004
  end-page: 221
  ident: bib6
  article-title: Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig
  publication-title: European Journal of Pharmacology
  contributor:
    fullname: Raunig
– volume: 11
  start-page: 187
  year: 1981
  end-page: 195
  ident: bib10
  article-title: The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: Concentration—effects relationships
  publication-title: British Journal of Clinical Pharmacology
  contributor:
    fullname: Sheiner
– volume: 26
  start-page: 761
  year: 1995
  end-page: 769
  ident: bib22
  article-title: Terfenadine blocks time-dependent Ca
  publication-title: Journal of Cardiovascular Pharmacology
  contributor:
    fullname: Nordin
– volume: 64
  start-page: 542
  year: 1998
  end-page: 546
  ident: bib30
  article-title: The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
  publication-title: Clinical Pharmacology and Therapeutics
  contributor:
    fullname: Burggraaf
– start-page: 151
  year: 2001
  end-page: 170
  ident: bib24
  publication-title: Myocardial Repolarization
  contributor:
    fullname: Breithardt
– volume: 31
  start-page: 633
  year: 2001
  end-page: 650
  ident: bib31
  article-title: Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog
  publication-title: Xenobiotica
  contributor:
    fullname: Leishman
– volume: 39
  start-page: 552
  year: 1990
  end-page: 574
  ident: bib19
  article-title: Terfenadine—An updated review of its pharmacological properties and therapeutic efficacy
  publication-title: Drugs
  contributor:
    fullname: Ferrill
– volume: 39
  start-page: 49
  year: 2000
  end-page: 75
  ident: bib20
  article-title: Drug interactions with cisapride. Clinical implications
  publication-title: Clinical Pharmacokinetics
  contributor:
    fullname: Williams
– volume: 6
  start-page: 533
  year: 2001
  end-page: 554
  ident: bib21
  article-title: Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: Pharmacodynamic model incorporating a site of adverse effect
  publication-title: Journal of Pharmacokinetics and Pharmacodynamics
  contributor:
    fullname: Iga
– volume: 269
  start-page: 1513
  year: 1993
  end-page: 1518
  ident: bib12
  article-title: Terfenadine–ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences
  publication-title: Journal of the American Medical Association
  contributor:
    fullname: Cantilena
– volume: 37
  start-page: 15
  year: 2004
  end-page: 24
  ident: bib1
  article-title: Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?
  publication-title: Journal of Electrocardiology
  contributor:
    fullname: Antzelevitch
– volume: 23
  start-page: 374
  year: 1994
  end-page: 378
  ident: bib7
  article-title: Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias
  publication-title: Journal of Cardiovascular Pharmacology
  contributor:
    fullname: Inhoue
– volume: 21
  start-page: 39
  year: 1999
  end-page: 44
  ident: bib9
  article-title: Effects of H1 antihistamines on animal models of QTc prolongation
  publication-title: Drug Safety
  contributor:
    fullname: Llenas
– volume: 27
  start-page: 6
  year: 1992
  end-page: 12
  ident: bib13
  article-title: Heart rate—QT relationships during baroreceptor stimulation with diminished autonomic influence on the ventricles
  publication-title: Integrative Physiological and Behavioral Science
  contributor:
    fullname: Wolf
– volume: 26
  start-page: S807
  year: 1998
  end-page: S817
  ident: bib15
  article-title: Electrocardiographic effects of mizolastine and terfenadine in conscious dogs
  publication-title: Japanese Pharmacology & Therapeutics
  contributor:
    fullname: Gillet
– volume: 202
  start-page: 828
  year: 2002
  end-page: 833
  ident: bib5
  article-title: The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT–RR interval assessment
  publication-title: Journal of Pharmacology and Experimental Therapeutics
  contributor:
    fullname: Leishman
– volume: 9
  start-page: 280
  year: 2004
  end-page: 289
  ident: bib14
  article-title: Brugada and long QT-3 syndromes: Two phenotypes of the sodium channel disease
  publication-title: Annals of Noninvasive Electrocardiology
  contributor:
    fullname: Nair
– volume: 58
  start-page: 32
  year: 2003
  end-page: 45
  ident: bib25
  article-title: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and Torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development
  publication-title: Cardiovascular Research
  contributor:
    fullname: Palethorpe
– volume: 103
  start-page: 2004
  year: 2001
  end-page: 2013
  ident: bib11
  article-title: Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic
  publication-title: Circulation
  contributor:
    fullname: Duker
– volume: 8
  start-page: 117
  year: 2001
  end-page: 122
  ident: bib32
  article-title: Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography
  publication-title: American Journal of Therapeutics
  contributor:
    fullname: Somberg
– volume: 14
  start-page: 1356
  year: 2003
  end-page: 1360
  ident: bib23
  article-title: Atrioventricular nodal ablation and His-Bundle pacing: An acute model for proarrhythmic risk assessment
  publication-title: Journal of Cardiovascular Electrophysiology
  contributor:
    fullname: Girand
– volume: 13
  start-page: 49
  year: 1998
  end-page: 57
  ident: bib29
  article-title: Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model
  publication-title: Heart and Vessels
  contributor:
    fullname: Hashimoto
– volume: 16
  start-page: 161
  year: 2002
  end-page: 173
  ident: bib26
  article-title: Safety pharmacology—A progressive approach
  publication-title: Fundamental and Clinical Pharmacology
  contributor:
    fullname: Valentin
– volume: 50
  start-page: 673
  year: 1991
  end-page: 681
  ident: bib8
  article-title: Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis
  publication-title: Clinical Pharmacology and Therapeutics
  contributor:
    fullname: Seiler
– volume: 22
  start-page: 1397
  year: 1999
  end-page: 1401
  ident: bib2
  article-title: Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms
  publication-title: Pacing and Clinical Electrophysiology
  contributor:
    fullname: Malik
– volume: 350
  start-page: 1013
  year: 2004
  end-page: 1022
  ident: bib27
  article-title: Drug-induced prolongation of the QT interval
  publication-title: The New England Journal of Medicine
  contributor:
    fullname: Roden
– volume: 12
  start-page: 411
  year: 2001
  end-page: 420
  ident: bib17
  article-title: Problems of heart rate correction in assessment of drug-induced QT interval prolongation
  publication-title: Journal of Cardiovascular Electrophysiology
  contributor:
    fullname: Malik
– volume: 25
  start-page: 209
  year: 2002
  end-page: 216
  ident: bib18
  article-title: The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes
  publication-title: Pacing and Clinical Electrophysiology
  contributor:
    fullname: Malik
– volume: 39
  start-page: 1820
  year: 2002
  end-page: 1826
  ident: bib16
  article-title: Autonomic nervous system influences on QT interval in normal subjects
  publication-title: Journal of the American College of Cardiology
  contributor:
    fullname: Bloomfield
– volume: 27
  start-page: 1475
  year: 2004
  end-page: 1483
  ident: bib28
  article-title: Stability of ventricular repolarization in conscious dogs with chronic atrioventricular dissociation and His-Bundle pacing
  publication-title: Pacing and Clinical Electrophysiology
  contributor:
    fullname: Olivier
– volume: 64
  start-page: 93
  year: 1998
  end-page: 95
  ident: bib4
  article-title: Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes
  publication-title: International Journal of Cardiology
  contributor:
    fullname: Manolis
– volume: 64
  start-page: 542
  year: 1998
  ident: 10.1016/j.vascn.2005.02.003_bib30
  article-title: The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
  publication-title: Clinical Pharmacology and Therapeutics
  doi: 10.1016/S0009-9236(98)90137-0
  contributor:
    fullname: Van Haarst
– volume: 64
  start-page: 93
  issue: 1
  year: 1998
  ident: 10.1016/j.vascn.2005.02.003_bib4
  article-title: Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes
  publication-title: International Journal of Cardiology
  doi: 10.1016/S0167-5273(97)00331-8
  contributor:
    fullname: Chiladakis
– volume: 13
  start-page: 49
  year: 1998
  ident: 10.1016/j.vascn.2005.02.003_bib29
  article-title: Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model
  publication-title: Heart and Vessels
  doi: 10.1007/BF01744586
  contributor:
    fullname: Usui
– volume: 486
  start-page: 209
  year: 2004
  ident: 10.1016/j.vascn.2005.02.003_bib6
  article-title: Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig
  publication-title: European Journal of Pharmacology
  doi: 10.1016/j.ejphar.2003.12.028
  contributor:
    fullname: Fossa
– volume: 31
  start-page: 633
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib31
  article-title: Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog
  publication-title: Xenobiotica
  doi: 10.1080/00498250110054632
  contributor:
    fullname: Webster
– volume: 6
  start-page: 533
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib21
  article-title: Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: Pharmacodynamic model incorporating a site of adverse effect
  publication-title: Journal of Pharmacokinetics and Pharmacodynamics
  doi: 10.1023/A:1014460404352
  contributor:
    fullname: Minematsu
– volume: 350
  start-page: 1013
  issue: 10
  year: 2004
  ident: 10.1016/j.vascn.2005.02.003_bib27
  article-title: Drug-induced prolongation of the QT interval
  publication-title: The New England Journal of Medicine
  doi: 10.1056/NEJMra032426
  contributor:
    fullname: Roden
– volume: 26
  start-page: S807
  year: 1998
  ident: 10.1016/j.vascn.2005.02.003_bib15
  article-title: Electrocardiographic effects of mizolastine and terfenadine in conscious dogs
  publication-title: Japanese Pharmacology & Therapeutics
  contributor:
    fullname: Lainee
– volume: 12
  start-page: 411
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib17
  article-title: Problems of heart rate correction in assessment of drug-induced QT interval prolongation
  publication-title: Journal of Cardiovascular Electrophysiology
  doi: 10.1046/j.1540-8167.2001.00411.x
  contributor:
    fullname: Malik
– volume: 14
  start-page: 1356
  year: 2003
  ident: 10.1016/j.vascn.2005.02.003_bib23
  article-title: Atrioventricular nodal ablation and His-Bundle pacing: An acute model for proarrhythmic risk assessment
  publication-title: Journal of Cardiovascular Electrophysiology
  doi: 10.1046/j.1540-8167.2003.03215.x
  contributor:
    fullname: Olivier
– volume: 25
  start-page: 209
  year: 2002
  ident: 10.1016/j.vascn.2005.02.003_bib18
  article-title: The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes
  publication-title: Pacing and Clinical Electrophysiology
  doi: 10.1046/j.1460-9592.2002.00209.x
  contributor:
    fullname: Malik
– volume: 58
  start-page: 32
  year: 2003
  ident: 10.1016/j.vascn.2005.02.003_bib25
  article-title: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and Torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development
  publication-title: Cardiovascular Research
  doi: 10.1016/S0008-6363(02)00846-5
  contributor:
    fullname: Redfern
– volume: 39
  start-page: 49
  issue: 1
  year: 2000
  ident: 10.1016/j.vascn.2005.02.003_bib20
  article-title: Drug interactions with cisapride. Clinical implications
  publication-title: Clinical Pharmacokinetics
  doi: 10.2165/00003088-200039010-00004
  contributor:
    fullname: Michalets
– volume: 39
  start-page: 552
  year: 1990
  ident: 10.1016/j.vascn.2005.02.003_bib19
  article-title: Terfenadine—An updated review of its pharmacological properties and therapeutic efficacy
  publication-title: Drugs
  doi: 10.2165/00003495-199039040-00006
  contributor:
    fullname: McTavish
– volume: 23
  start-page: 374
  year: 1994
  ident: 10.1016/j.vascn.2005.02.003_bib7
  article-title: Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias
  publication-title: Journal of Cardiovascular Pharmacology
  doi: 10.1097/00005344-199423030-00003
  contributor:
    fullname: Fujiki
– volume: 27
  start-page: 1475
  year: 2004
  ident: 10.1016/j.vascn.2005.02.003_bib28
  article-title: Stability of ventricular repolarization in conscious dogs with chronic atrioventricular dissociation and His-Bundle pacing
  publication-title: Pacing and Clinical Electrophysiology
  doi: 10.1111/j.1540-8159.2004.00664.x
  contributor:
    fullname: Sanders
– volume: 27
  start-page: 6
  issue: 1
  year: 1992
  ident: 10.1016/j.vascn.2005.02.003_bib13
  article-title: Heart rate—QT relationships during baroreceptor stimulation with diminished autonomic influence on the ventricles
  publication-title: Integrative Physiological and Behavioral Science
  doi: 10.1007/BF02691087
  contributor:
    fullname: Huang
– volume: 8
  start-page: 117
  issue: 2
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib32
  article-title: Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography
  publication-title: American Journal of Therapeutics
  doi: 10.1097/00045391-200103000-00006
  contributor:
    fullname: Yelamanchi
– volume: 55
  start-page: 253
  year: 1986
  ident: 10.1016/j.vascn.2005.02.003_bib3
  article-title: Diurnal variation of the QT interval—influence of the autonomic nervous system
  publication-title: British Heart Journal
  doi: 10.1136/hrt.55.3.253
  contributor:
    fullname: Bexton
– volume: 50
  start-page: 673
  issue: 6
  year: 1991
  ident: 10.1016/j.vascn.2005.02.003_bib8
  article-title: Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis
  publication-title: Clinical Pharmacology and Therapeutics
  doi: 10.1038/clpt.1991.206
  contributor:
    fullname: Gladziwa
– volume: 11
  start-page: 187
  year: 1981
  ident: 10.1016/j.vascn.2005.02.003_bib10
  article-title: The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: Concentration—effects relationships
  publication-title: British Journal of Clinical Pharmacology
  doi: 10.1111/j.1365-2125.1981.tb01123.x
  contributor:
    fullname: Holford
– volume: 39
  start-page: 1820
  year: 2002
  ident: 10.1016/j.vascn.2005.02.003_bib16
  article-title: Autonomic nervous system influences on QT interval in normal subjects
  publication-title: Journal of the American College of Cardiology
  doi: 10.1016/S0735-1097(02)01852-1
  contributor:
    fullname: Magnano
– start-page: 151
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib24
  contributor:
    fullname: Oto
– volume: 22
  start-page: 1397
  year: 1999
  ident: 10.1016/j.vascn.2005.02.003_bib2
  article-title: Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms
  publication-title: Pacing and Clinical Electrophysiology
  doi: 10.1111/j.1540-8159.1999.tb00635.x
  contributor:
    fullname: Aytemir
– volume: 9
  start-page: 280
  issue: 3
  year: 2004
  ident: 10.1016/j.vascn.2005.02.003_bib14
  article-title: Brugada and long QT-3 syndromes: Two phenotypes of the sodium channel disease
  publication-title: Annals of Noninvasive Electrocardiology
  doi: 10.1111/j.1542-474X.2004.93533.x
  contributor:
    fullname: Khan
– volume: 26
  start-page: 761
  year: 1995
  ident: 10.1016/j.vascn.2005.02.003_bib22
  article-title: Terfenadine blocks time-dependent Ca2+, Na+ and K+ channels in guinea pig ventricular myocytes
  publication-title: Journal of Cardiovascular Pharmacology
  doi: 10.1097/00005344-199511000-00013
  contributor:
    fullname: Ming
– volume: 103
  start-page: 2004
  year: 2001
  ident: 10.1016/j.vascn.2005.02.003_bib11
  article-title: Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.15.2004
  contributor:
    fullname: Hondeghem
– volume: 37
  start-page: 15
  year: 2004
  ident: 10.1016/j.vascn.2005.02.003_bib1
  article-title: Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?
  publication-title: Journal of Electrocardiology
  doi: 10.1016/j.jelectrocard.2004.08.004
  contributor:
    fullname: Antzelevitch
– volume: 202
  start-page: 828
  year: 2002
  ident: 10.1016/j.vascn.2005.02.003_bib5
  article-title: The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT–RR interval assessment
  publication-title: Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1124/jpet.102.035220
  contributor:
    fullname: Fossa
– volume: 21
  start-page: 39
  issue: Supplement 1
  year: 1999
  ident: 10.1016/j.vascn.2005.02.003_bib9
  article-title: Effects of H1 antihistamines on animal models of QTc prolongation
  publication-title: Drug Safety
  doi: 10.2165/00002018-199921001-00006
  contributor:
    fullname: Gras
– volume: 269
  start-page: 1513
  year: 1993
  ident: 10.1016/j.vascn.2005.02.003_bib12
  article-title: Terfenadine–ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences
  publication-title: Journal of the American Medical Association
  doi: 10.1001/jama.1993.03500120051025
  contributor:
    fullname: Honig
– volume: 16
  start-page: 161
  year: 2002
  ident: 10.1016/j.vascn.2005.02.003_bib26
  article-title: Safety pharmacology—A progressive approach
  publication-title: Fundamental and Clinical Pharmacology
  doi: 10.1046/j.1472-8206.2002.00098.x
  contributor:
    fullname: Redfern
SSID ssj0003914
Score 1.8397208
Snippet Introduction: Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the...
Terfenadine, cisapride, and E-4031, three drugs that prolong ventricular repolarization, were selected to evaluate the sensitivity of the conscious chronic...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Animals
Anti-Arrhythmia Agents - blood
Anti-Arrhythmia Agents - pharmacokinetics
Anti-Arrhythmia Agents - toxicity
Atrioventricular Node - surgery
Bundle of His - surgery
Cardiac Pacing, Artificial
Cardiovascular
Catheter Ablation
Cisapride - blood
Cisapride - pharmacokinetics
Cisapride - toxicity
Dog
Dogs
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical - methods
Electrocardiography - drug effects
Gastrointestinal Agents - blood
Gastrointestinal Agents - pharmacokinetics
Gastrointestinal Agents - toxicity
His bundle-pacing
Histamine H1 Antagonists - blood
Histamine H1 Antagonists - pharmacokinetics
Histamine H1 Antagonists - toxicity
Ion Channels - antagonists & inhibitors
Long QT Syndrome - etiology
Male
Methods
Models, Animal
Models, Biological
Pharmacokinetic/pharmacodynamic modeling
Piperidines - blood
Piperidines - pharmacokinetics
Piperidines - toxicity
Pyridines - blood
Pyridines - pharmacokinetics
Pyridines - toxicity
QT interval
Repolarization
Terfenadine - blood
Terfenadine - pharmacokinetics
Terfenadine - toxicity
Title A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node—ablated, His bundle-paced dog
URI https://dx.doi.org/10.1016/j.vascn.2005.02.003
https://www.ncbi.nlm.nih.gov/pubmed/16399550
https://search.proquest.com/docview/17458119
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELba7QEuCMpreZQ5oJ4Sdp3YSXxcrVotIKpKtFJvkV-pApUT7UvqBfEj-G38AH4J48RhxaEcOCbKJJY9mfnGM_6GkLdFZoVUVMRaCR2zjGX4S3EVGypTrnO0m91KfzrLFpfswxW_2iPz4SyML6sMtr-36Z21DncmYTYnbV1PPvue8Qj3xZR3LC58nxygO2JsRA5m7z8uzv4Y5FR0FN_--dgLDORDXZmXL_h0YW_Fc3emdzmouwBo54hOH5IHAUHCrB_kI7Jn3SG5Nx8atx2S4_Oejvo2govd6apVBMdwviOqvn1Mfs7ANVt7A-3Sp2u84YM2PPEV0SdKTYZr03euh65zDjQV-GQDRsXhGCe-Al_qrvsLg2q9tQb82RVAhAmhasTL-bbY1heaORuBrleyXdbGgnQGTjDMTCnUrpPBQB0XpNmsQPcEviC3OF5jf33_IdUNYmQTwaJegdp4oogYg3_8pGmun5DL05OL-SIOfR5inWZiHReMKSnTPEkq9J00p9JqjHsqXsgKzYlM9NQmeeFTsIYzq02KqFIYrXJuxFRN06dk5BpnnxOwiIeUp5yhuWFVkqlccZbIpNI0E5LpMYmGxS3bns6jHOrcvpSdLvjGnLycJp41dUyyQQHKv7SyRIfzb8E3g7qUuPo-CSOdxSkrMQLkBaViTJ71WrQbhweLGDC--N-PviT3dxtEr8hovdzY1wiZ1uqI7L_7Ro_Cj_Eb6xUaOw
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV25btwwECWcdeE0QeJcm8tTBK4krA5SEsvFwoYc2wsDWQPuBF4y5BiSsBfgLh-Rb8sH5EsylKgsUjhFSgoakiCHwzfk8A0hn7PEcCFD7ivJlU8TmuCSYtLXoYiZStFudjN9OU_ya_rlht3skdnwFsaGVTrb39v0zlq7LxM3mpO2qiZfbc54hPs8YB2LC3tC9ilLQzoi-9Oz83z-xyDHvKP4tv_7VmAgH-rCvGzAZ-3OVix3Z_zYBvUYAO02otPn5JlDkDDtO_mC7Jn6kBzMhsRth-T4qqejfvBgsXtdtfLgGK52RNUPL8nPKdTN1txDu7TXNdbwQev--IboE6UmQ1n3meuhy5wDTQn2sgG9YveME6vASuvbvqBRrbdGg327AogwwUWNWDmbFtvYQLPaeKCqlWiXlTYgag0n6GbGIVR1J4OOOk5Is1mB6gl8QWyxv9r8-v5DyHvEyNqDvFqB3FiiCB-df2xSN7evyPXpyWKW-y7Pg6_ihK_9jFIpRJxGUYl7Z5iGwij0e0qWiRLNiYhUYKI0s1ewmlGjdIyokmslU6Z5IIP4NRnVTW3eEjCIh6SlnAlTTcsokalkNBJRqcKEC6rGxBsmt2h7Oo9iiHO7KzpdsIk5WRFEljV1TJJBAYq_tLLADeffgkeDuhQ4-_YSRtQGh6xAD5BlYcjH5E2vRbt-WLCIDuO7_230iBzki8uL4uJsfv6ePN0dFn0go_VyYz4ifFrLT255_Aa0pRwt
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+predictive+pharmacokinetic%2Fpharmacodynamic+model+of+repolarization+prolongation+derived+from+the+effects+of+terfenadine%2C+cisapride+and+E-4031+in+the+conscious+chronic+av+node--ablated%2C+His+bundle-paced+dog&rft.jtitle=Journal+of+pharmacological+and+toxicological+methods&rft.au=Nolan%2C+Emily+R&rft.au=Feng%2C+Meihua+Rose&rft.au=Koup%2C+Jeffrey+R&rft.au=Liu%2C+Jing&rft.date=2006-01-01&rft.issn=1056-8719&rft.volume=53&rft.issue=1&rft.spage=1&rft_id=info:doi/10.1016%2Fj.vascn.2005.02.003&rft_id=info%3Apmid%2F16399550&rft.externalDocID=16399550
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1056-8719&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1056-8719&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1056-8719&client=summon